Celerion

About Celerion

Celerion provides translational medicine and clinical research services focused on accelerating early-phase drug development. With global operations, the company offers expertise in bioanalytical sciences, pharmacokinetics/pharmacodynamics, and data management to help clients make informed decisions and bring products to market faster. Its capabilities span early-phase centers, phase 2-3 trial design, biomarker research, and regulatory affairs support for multinational investigations. Celerion emphasizes agile, innovative research and patient-centered trials across therapeutic areas to support drug development worldwide.